Bristol-Myers Squibb Company (BMY) · page 118 of 197
Uses a combination of a line chart and qualitative quotes to build a bearish case on CAR-T commercial viability.
Activist deck · expose_contradiction · expose_contradiction · overcrowded density
Slide locked Sign in to view
Slide schematic 7/7
callout 1/1 chart 1/1 paragraph 1/1 quote 2/2 title 2/2
Components 7
primary line paragraph pull-quote pull-quote action-title headline
Tools 0
∅
No tools
No canon tool match is anchored to this slide.
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 1